A machine learning-based electronic nose for detecting neonatal sepsis: Analysis of volatile organic compound biomarkers in fecal samples
Penulis/Author
KOMBO, KOMBO (1); SHIDIQ NUR HIDAYAT (2); MAYUMI PUSPITA (3); Dr.Eng. Ahmad Kusumaatmaja, S.Si., M.Sc. (4); Prof. Drs. Roto, M.Eng, Ph.D. (5); Prof. Dr. dr. Hera Nirwati, M.Kes., Sp.MK. (6); dr. Rina Susilowati, Ph.D. (7); Dr. dr.. Ekawaty Lutfia Haksari, MPH., Sp.A(K). (8); Dr. dr. Tunjung Wibowo, MPH., M.Kes., Sp.A(K). (9); dr. Setya Wandita, M.Kes., Sp.A(K). (10); Wahyono, Ph.D. (11); Prof. dr. Madarina Julia, Sp.A(K), MPH., Ph.D. (12); Prof. Dr. Eng. Kuwat Triyana, M.Si. (13)
Tanggal/Date
15 2025
Kata Kunci/Keyword
Abstrak/Abstract
Neonatal sepsis is a global health threat, contributing to high morbidity and mortality rates among newborns. Recognizing the profound impact of neonatal sepsis on long-term health outcomes emphasizes the critical need for timely detection to mitigate its consequences and ensure optimal health for the affected newborns. Currently, various diagnostic approaches have been implemented, but they are limited by their invasiveness, high costs, centralized testing, frequent delays, inaccuracies in results, and the need for sophisticated laboratory equipment. We introduced a novel, non-invasive, cost-efficient, and easy-to-use technology that can provide rapid results at a point-of-care. The technology utilized a lab-built metal oxide semiconductor-based electronic nose (cNose) combined with volatile organic compound (VOC) biomarkers identified through gas chromatography-mass spectrometry (GC–MS) analysis. The system was evaluated using fecal profiling tests involving a total of 32 samples, including 17 positive and 15 negative sepsis, confirmed by blood culture. To assess the performance in discriminating patients from healthy controls, four machine learning algorithms were implemented. Based on the cross-validation results, the MLPNN model provided the best results in distinguishing between neonates with positive and negative sepsis, achieving high-performance results of 90.63 ?curacy, 88.24 % sensitivity, and 93.33 % specificity at a 95 % confidence interval. Specific VOCs associated with neonatal sepsis, such as alcohols, acids, and esters, were successfully identified through GC–MS analysis, further validating the diagnostic capability of the cNose device. The overall observations show the feasibility of using cNose system as a promising tool for real-time and bedside sepsis detection, potentially improving patient outcomes.
